Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
83%
Ph phase_2
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(1)
Other(3)

Detailed Status

unknown3
Completed1
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (16.7%)
N/A5 (83.3%)

Trials by Status

completed117%
unknown350%
recruiting117%
active_not_recruiting117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
PROCEDURE
Total Trials
6